578-Page Report Forecasts Market Growth from $3.18B (2026) to $5.7B by 2031, Profiling 10x Genomics, Thermo Fisher, Illumina, Oxford Nanopore, Bruker, and 14 Other Key Players
Multiomics Market
Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) — The “Multiomics Market by Offerings, Method, Technology, Workflow, Application, Competition – Global Forecast to 2031” has been added to ResearchAndMarkets.com’s offering.
Global Multiomics Market to Reach USD 5.70 Billion by 2031, Driven by Precision Medicine and Advanced Omics Technologies
The global multiomics market is projected to grow from USD 3.18 billion in 2026 to USD 5.70 billion by 2031, registering a compound annual growth rate (CAGR) of 12.3% during the forecast period. Market expansion is being driven by the increasing integration of genomic, transcriptomic, proteomic, metabolomic, and epigenomic profiling across oncology, drug discovery, precision medicine, and translational research.
Advances in single-cell analysis, spatial omics, next-generation sequencing (NGS), mass spectrometry, artificial intelligence, machine learning, and cloud bioinformatics are accelerating multiomics adoption. Greater access to high-quality integrated omics data is also supporting disease stratification, biomarker discovery, therapeutic development, and cross-omics data interpretation. However, high technology costs, complex data integration and standardization requirements, and limited access to specialized computational expertise may restrict adoption in resource-constrained research settings.
Products Led the Multiomics Market by Offering in 2025
Based on offering, the market is segmented into products and services. Products accounted for the largest market share in 2025, supported by demand for sequencing platforms, analytical instruments, assay kits, reagents, consumables, and software used throughout multiomics workflows. These products support sample preparation, sequencing, molecular characterization, and data analysis across pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories.
The services segment is forecast to record the fastest growth through 2031. Growth will be supported by increased outsourcing of complex multiomics profiling, bioinformatics analysis, and integrated omics interpretation to specialized service providers.
Single-Cell Omics Held the Largest Method Share
By method, the multiomics market includes epigenomics, single-cell omics, spatial omics, long-read and long-range sequencing, proteomics, and other methods. Single-cell omics held the largest share in 2025 due to expanding use in cellular heterogeneity analysis and molecular interaction profiling at individual-cell resolution. Adoption is increasing across oncology, immunology, developmental biology, and drug discovery.
Spatial omics is expected to register the fastest growth during the forecast period, reflecting rising demand for technologies that preserve tissue architecture while enabling simultaneous molecular profiling. Key market opportunities also include growing adoption of spatial proteomics for tissue-context analysis and biomarker discovery, alongside the emergence of single-cell proteomics for high-resolution cellular profiling.
Asia Pacific to Register the Highest CAGR Through 2031
The report evaluates North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is projected to achieve the highest CAGR from 2026 to 2031, driven by investments in genomics and life sciences research, expanding precision medicine programs, and increased adoption of NGS, single-cell technologies, spatial biology, and high-resolution mass spectrometry.
Government funding for omics research, expanding biotechnology and pharmaceutical R&D, advanced research infrastructure, and the growing presence of contract research organizations and genomic service providers are strengthening the regional market. The presence of BGI Genomics and Novogene, together with continued investment by global multiomics technology providers, is advancing regional capabilities in biomarker discovery, multiomics research, and precision medicine.
Competitive Landscape and Companies Profiled
The multiomics market report assesses established companies and emerging startups, including their market shares, product portfolios, growth strategies, approvals, product and service launches, collaborations, partnerships, expansions, agreements, investments, and recent industry developments.
- 10x Genomics, Inc.
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Oxford Nanopore Technologies plc
- Bruker Corporation
- PacBio
- Danaher Corporation
- Vizgen Corporation
- Agilent Technologies, Inc.
- Biognosys AG
- Merck KGaA
- QIAGEN N.V.
- Revvity, Inc.
- Waters Corporation
- Syngene International
- Bio-Rad Laboratories, Inc.
- Takara Bio Inc.
- Metabolon, Inc.
- BGI Genomics Co., Ltd.
The competitive assessment includes leading participants such as 10x Genomics, Thermo Fisher Scientific, Illumina, Oxford Nanopore Technologies, and Bruker, as well as other companies operating across the multiomics ecosystem.
Research Coverage
The research categorizes the global multiomics market by offering, method, technology, workflow, application, end user, and region. It analyzes major growth drivers, restraints, opportunities, and challenges, including the adoption of multiomics in precision medicine and disease stratification; rapid growth in single-cell and spatial multiomics; advances in AI-enabled data analysis; technology costs; data integration complexity; and the lack of standardized workflows.
The report also provides detailed coverage of product development and innovation, newly launched products, regional market opportunities, untapped geographies, investments, market diversification, and recent developments. Revenue estimates for the overall market and its subsegments are designed to help established participants and new entrants evaluate the competitive landscape, strengthen market positioning, and develop effective go-to-market strategies.
Primary Research Breakdown
- By respondent: Supply side, 70%; demand side, 30%
- By company type: Tier 1, 40%; Tier 2, 30%; Tier 3, 30%
- By designation: CXOs and directors, 30%; managers, 45%; others, 25%
- By region: North America, 40%; Europe, 25%; Asia Pacific, 20%; Latin America, 10%; Middle East and Africa, 5%
The findings provide stakeholders with actionable insight into multiomics market revenue, high-growth segments, competitive dynamics, innovation trends, regional expansion opportunities, and the factors expected to shape the industry through 2031.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 578 |
| Forecast Period | 2026 – 2031 |
| Estimated Market Value (USD) in 2026 | $3.18 Billion |
| Forecasted Market Value (USD) by 2031 | $5.7 Billion |
| Compound Annual Growth Rate | 12.3% |
Key Topics Covered:
Market Dynamics
Drivers
- Rising Use of Multiomics in Precision Medicine and Disease Stratification
- Rapid Adoption of Single-Cell and Spatial Multiomics
- Increasing Accessibility of High-Quality, Integrated Omics Data for Research
- AI, Machine Learning, and Cloud Bioinformatics Improving Cross-Omics Interpretation
Challenges
- Restraints
- Complexity of Multiomics Data Integration and Standardization
- High Costs Constrain Technology Adoption
- Challenges
- Lack of Standardization Across Multiomics Workflows
Case Studies
- Advanced Multiomics Profiling to Support Precision Medicine Adoption
- Integrated Long-Read Sequencing to Support Multiomics Research
- Multiomics Data Integration to Accelerate Biomarker Discovery
Industry Trends
- Porter’s Five Forces Analysis
- Threat of New Entrants
- Threat of Substitutes
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Intensity of Competitive Rivalry
- Macroeconomic Outlook
- Introduction
- GDP Trends and Forecast
- Trends in Global Healthcare Industry
- Trends in Global Pharmaceutical Industry
- Value Chain Analysis
- Ecosystem Analysis
- Pricing Analysis
- Average Selling Price Trend of Instruments, by Type (2023-2025)
- Average Selling Price Trend of Consumables, by Type, 2023-2025
- Average Selling Price Trend, by Region, 2023-2025
- Trade Analysis
- Import Data for Hs Code 9027
- Export Data for Hs Code 9027
- Import Volume for Hs Code 9027
- Export Volume for Hs Code 9027
- Key Conferences & Events
- Trends/Disruptions Impacting Customers’ Businesses
- Investment/Funding Activity
- Impact of 2025 US Tariffs – Multiomics Market
- Introduction
- Key Tariff Rates
- Price Impact Analysis
- Impact on Countries/Regions
- North America
- Europe
- Asia-Pacific
- Impact on End-Use Industries
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Academic & Research Institutes
- Cros & Cdmos
Opportunities
- Growing Adoption of Spatial Proteomics for Tissue-Context Analysis and Biomarker Discovery
- Increasing Emergence of Single-Cell Proteomics for High-Resolution Characterization of Cellular Profiles
For more information about this report visit https://www.researchandmarkets.com/r/k3hjj3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
- Multiomics Market
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
